Lupin Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUPIN PHARMS, and what generic and branded alternatives to LUPIN PHARMS drugs are available?
LUPIN PHARMS has eleven approved drugs.
There are two tentative approvals on LUPIN PHARMS drugs.
Summary for Lupin Pharms
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 11 |
Drugs and US Patents for Lupin Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Pharms | MELOXICAM | meloxicam | TABLET;ORAL | 077944-001 | Jul 19, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin Pharms | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | amlodipine besylate; benazepril hydrochloride | CAPSULE;ORAL | 078466-005 | Jul 5, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin Pharms | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 077560-002 | Mar 2, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LUPIN PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Oral Suspension | 500 mg/5 mL | ➤ Subscribe | 2014-07-22 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
